Cargando…
Glioblastoma Relapses Show Increased Markers of Vulnerability to Ferroptosis
BACKGROUND: Despite the availability of various therapy options and being a widely focused research area, the prognosis of glioblastoma (GBM) still remains very poor due to therapy resistance, genetic heterogeneity and a diffuse infiltration pattern. The recently described non-apoptotic form of cell...
Autores principales: | Kram, Helena, Prokop, Georg, Haller, Bernhard, Gempt, Jens, Wu, Yang, Schmidt-Graf, Friederike, Schlegel, Jürgen, Conrad, Marcus, Liesche-Starnecker, Friederike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071304/ https://www.ncbi.nlm.nih.gov/pubmed/35530303 http://dx.doi.org/10.3389/fonc.2022.841418 |
Ejemplares similares
-
ALDH1-Mediated Autophagy Sensitizes Glioblastoma Cells to Ferroptosis
por: Wu, Yang, et al.
Publicado: (2022) -
Enhanced Sensitivity to ALDH1A3-Dependent Ferroptosis in TMZ-Resistant Glioblastoma Cells
por: Wu, Yang, et al.
Publicado: (2023) -
Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human Glioblastoma
por: Liesche-Starnecker, Friederike, et al.
Publicado: (2020) -
Visualizing cellularity and angiogenesis in newly-diagnosed glioblastoma with diffusion and perfusion MRI and FET-PET imaging
por: Liesche-Starnecker, Friederike, et al.
Publicado: (2021) -
The Intratumoral Heterogeneity Reflects the Intertumoral Subtypes of Glioblastoma Multiforme: A Regional Immunohistochemistry Analysis
por: Bergmann, Natalie, et al.
Publicado: (2020)